Head of Department

Clinical and Interventional Angiology, Asklepios Klinik, Hamburg, Germany.

MEDICAL SCHOOL

  1. 1979 – 10. 1985 Medical School, Technical University Aachen, Germany

DOCTOR’S THESIS

  1. 1988 Technical University of Aachen; Department of History of Medicine, Prof. Dr. med. A. H. Murken; “The History of the health system and the traditional medicine of the Caribbean island of Dominica”

POSTDOCTORAL TRAINING

  1. 1986 – 11. 1988 University Hospital, Technical University Aachen, Germany

Thoracic and Cardiovascular Surgery

Director: Prof. Dr. med. B. J. Messmer

 

  1. 1988 – 03. 1991 Maria Hilf Hospital, Mönchengladbach, Germany

Internal Medicine, Cardiology

Directors: Prof. Dr. med. D. Larbig, Prof. Dr. med. H.-E. Reis

 

  1. 1991 – 06. 1992 St. Elizabeth’s Medical Center, Tufts University, Boston, USA

Cardiovascular Research

Chief: Jeffrey M. Isner, M.D.

 

  1. 1992 – 09. 2001 Klinikum Großhadern, Ludwig Maximilian University, Munich, Germany

Medical Clinic I

Directors:   Prof. Dr. med. G. Riecker, Prof. Dr . med. G. Steinbeck

 

  1. 2001 – 01. 2009 Professor for Molecular Cardiology; Chief, Angiology

University Hospital, Westfälische Wilhelm University, Münster

Department of Cardiology and Angiology

Director: Prof. Dr. med. G. Breithardt

 

From 02. 2009              Head, Clinical and Interventional Angiology

Asklepios Clinic St. Georg, Hamburg

Campus Medical School Semmelweis University

CLINICAL ACCREDITATION

  1. 1997 Internal Medicine Boards
  2. 1999 Cardiology Boards
  3. 2005 Vascular Medicine Boards

 

 

HABILITATION  

  1. 1999 Ludwig Maximilian Universität München

Habilitation in Internal Medicine

„Gene therapy for the prevention of restenosis following angioplasty“

 

ACADEMIC APPOINTMENTS

  1. 1999 Assistant Professor of Medicine

Ludwig Maximilian University, Munich, Germany

 

  1. 2001 Associate Professor for Molecular Cardiology

Westfälische Wilhelm University, Münster, Germany

 

 

RESEARCH

 

Major Research Fields since 1992

Atherosclerosis Research, including role of chlamydia

Pathophysiology of restenosis post-angioplasty

Gene and drug therapy for the prevention of restenosis

Gene therapy for the induction of angiogenesis

Cardiovascular local drug delivery

Regeneration of myocardium and vasculature (stem cell and cytokine therapy)

 

 

Principal Investigator

Several interventional and gene or cell therapy clinical trials

 

 

PAST-President European Society for Vascular Medicine (ESVM)

See full disclosure of interest »